Hematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation, AutologousStem CellsPeripheral Blood Stem Cell TransplantationTransplantation ConditioningGraft vs Host DiseaseHematologic NeoplasmsBone Marrow TransplantationLiver TransplantationHematopoietic Stem CellsTransplantation ChimeraMesenchymal Stem Cell TransplantationTreatment OutcomeTissue DonorsCord Blood Stem Cell TransplantationGraft SurvivalKidney TransplantationCell TransplantationEmbryonic Stem CellsMyeloablative AgonistsAdult Stem CellsBusulfanRecurrenceHistocompatibility TestingMultiple MyelomaWhole-Body IrradiationCombined Modality TherapyRemission InductionMelphalanRetrospective StudiesImmunosuppressive AgentsHistocompatibilityHematopoietic Stem Cell MobilizationGraft vs Leukemia EffectHeart TransplantationPluripotent Stem CellsCell DifferentiationLeukemiaLung TransplantationTransplantation ImmunologyStem Cell NicheNeural Stem CellsDisease-Free SurvivalVidarabineSurvival RateTime FactorsSurvival AnalysisMesenchymal Stromal CellsCyclophosphamideAntigens, CD34Graft RejectionAntineoplastic Combined Chemotherapy ProtocolsHepatic Veno-Occlusive DiseaseSalvage TherapyInduced Pluripotent Stem CellsOrgan TransplantationLeukemia, Myeloid, AcuteChimerismGraft vs Tumor EffectTransplantation, IsogeneicSiblingsHLA AntigensHematologic DiseasesLymphocyte TransfusionMyelodysplastic SyndromesFollow-Up StudiesTransplantationMultipotent Stem CellsLymphoma, Non-HodgkinIslets of Langerhans TransplantationAntilymphocyte SerumImmunosuppressionGranulocyte Colony-Stimulating FactorPrecursor Cell Lymphoblastic Leukemia-LymphomaFetal Stem CellsBone Marrow CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsCell LineageHematopoiesisLymphocyte DepletionUnrelated DonorsCytarabineStem Cell FactorLiving DonorsHodgkin DiseaseCells, CulturedPrognosisPancreas TransplantationAnemia, AplasticAcute DiseaseEtoposideFlow CytometryT-LymphocytesCyclosporineLeukapheresisDonor SelectionCarmustine